Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol

por Feldman, Gregory J
Publicado 2013

Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease

por Feldman, Gregory J, Galkin, Dmitry V, Patel, Pinal, Collison, Kathryn A, Sharma, Raj
Publicado 2018

Efficacy and safety of olodaterol once daily delivered via Respimat(®) in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

por Ferguson, Gary T, Feldman, Gregory J, Hofbauer, Peter, Hamilton, Alan, Allen, Lisa, Korducki, Lawrence, Sachs, Paul
Publicado 2014

The 24-h FEV(1) time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover stud...

por Feldman, Gregory J, Bernstein, Jonathan A, Hamilton, Alan, Nivens, Michael C, Korducki, Lawrence, LaForce, Craig
Publicado 2014

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

por Feldman, Gregory J., Sousa, Ana R., Lipson, David A., Tombs, Lee, Barnes, Neil, Riley, John H., Patel, Sadhana, Naya, Ian, Compton, Chris, Alcázar Navarrete, Bernardino
Publicado 2017

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a...

por Martinez, Fernando J., Lipworth, Brian J., Rabe, Klaus F., Collier, David J., Ferguson, Gary T., Sethi, Sanjay, Feldman, Gregory J., O’Brien, Gerald, Jenkins, Martin, Reisner, Colin
Publicado 2020

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

por Crim, Courtney, Watkins, Michael L, Bateman, Eric D, Feldman, Gregory J, Schenkenberger, Isabelle, Kerwin, Edward M, Crawford, Catriona, Pudi, Krishna, Ho, Shuyen, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Publicado 2019